3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
28
Stomach Neoplasms
7
Esophageal Neoplasms
6
Inflammatory Breast Neoplasms
4
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Neoplasms
2
Sarcoma
1
Her2-Positive Breast Cancer
1
Esophageal Squamous Cell Carcinoma
1
Breast Neoplasms, Male
1
Adenocarcinoma
1
Interventions
pembrolizumab
3
Axitinib
2
regorafenib
1
avelumab
1
amivantamab
1
Tretinoin
1
Specimen Handling
1
Radiation
1
Pemetrexed
1
Nelfinavir
1
Magnetic Resonance Spectroscopy
1
Glutamate Carboxypeptidase II
1
GSK-3326595
1
Etoposide
1
Endoscopic Mucosal Resection
1
Doxorubicin
1
Cisplatin
1
Bortezomib
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Adenoid Cystic
×
Epirubicin
×
Clear all
No trials found.